News

C.W. Downer & Co. Advises Novozymes on Acquisition of Pacific Vet Group

BOSTON, November 17, 2015 – C.W. Downer & Co., a leading global middle-market investment bank,is pleased to announce that Novozymes US, Inc., a wholly owned subsidiary of Novozymes A/S—the world leader in bioinnovation—has acquired Pacific Vet Group – USA, Inc. (PVG). The deal closed on October 5, 2015 and the financial terms were not disclosed.

Based in Fayetteville, Arkansas, PVG develops and produces animal probiotics designed to improve the gut health of poultry. Probiotics are naturally occurring beneficial bacteria used to strengthen an animal’s gut flora and offer a natural alternative to antibiotics use.

Based in Denmark, Novozymes is a world leading biotechnology company focused on enzyme, microorganism and biopharmaceutical ingredients. Novozymes first entered the animal probiotic market through a May 2015 product development agreement with Adisseo, one of the world's leading experts in feed additives.

“PVG is a great fit with Novozymes as we continue to build our position as the leading innovation partner in probiotics for animals,” said Helle Warrer Poulsen, Vice President, Animal Health & Nutrition at Novozymes in a company statement. “With PVG we will get access to a promising pipeline and early product concepts targeted at the hatchery segment in the U.S. The PVG team has strong ties to academia and industry, and brings experience in the development of probiotics for animals. They will provide Novozymes with valuable insights and expertise, and further strengthen our partnerships.”

C.W. Downer & Co. has an extensive history assisting Novozymes with multiple acquisitions over the past fifteen years. Joseph Downing, Managing Director & Partner with C.W. Downer & Co. commented, “Through this acquisition, Novozymes continues to develop its business as a leading global provider of ingredients which benefit people and the environment. We value our long-term relationship with Novozymes and look forward to working with them on the growth of their animal probiotics business,” he concluded.

The C.W. Downer & Co. team assisting Novozymes with the acquisition included Mr. Downing (Managing Director & Partner) and Christopher Donegan (Director).

About C.W. Downer & Co.

C.W. Downer & Co. is an independent, global investment bank offering middle-market clients a high level of personal attention coupled with 40 years of international execution experience. We provide insight, not just information. We generate value, not just transactions. With nine fully integrated offices on four continents, we consistently identify the most appropriate strategic buyer and uncover “hidden” acquisition targets. C.W. Downer & Co. delivers the reach of a bulge-bracket investment bank with the senior level focus of a boutique. For more information, visit http://www.cwdowner.com.

For Additional Information:

Joseph Downing
Managing Director & Partner
This email address is being protected from spambots. You need JavaScript enabled to view it. +1 617 482 6200

Back to Previous

© 2015 by C.W. Downer & Co.

Downer & Company (d/b/a C.W. Downer & Co.) is a fully registered broker/dealer
and a member of the Financial Industry Regulatory Authority (FINRA).